Published in Prog Brain Res on January 01, 2002
Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry (2008) 1.48
Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. J Neurochem (2003) 0.85
Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48
Serial analysis of gene expression. Science (1995) 60.15
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (1992) 24.32
Exploring the new world of the genome with DNA microarrays. Nat Genet (1999) 19.05
Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A (1990) 11.10
Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol (1997) 9.09
Mitotic misregulation and human aging. Science (2000) 8.47
Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res (1979) 6.68
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
Limbic activation during cue-induced cocaine craving. Am J Psychiatry (1999) 6.66
Analysis of gene expression in single live neurons. Proc Natl Acad Sci U S A (1992) 6.15
Gene-expression profile of the ageing brain in mice. Nat Genet (2000) 5.46
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med (1988) 4.98
Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression. Nat Genet (1992) 4.69
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron (2000) 4.29
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry (2000) 3.44
Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94
The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci (1990) 2.54
Cocaine addiction: psychology and neurophysiology. Science (1991) 2.43
Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull (1989) 2.19
Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther (1997) 1.98
Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol (1992) 1.91
Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology (Berl) (1997) 1.87
Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol (2000) 1.80
Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm (1986) 1.75
Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry (1991) 1.64
Molecular alterations in the neostriatum of human cocaine addicts. Synapse (1993) 1.62
In situ transcription: specific synthesis of complementary DNA in fixed tissue sections. Science (1988) 1.59
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci (1996) 1.50
Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J Neurosci (1996) 1.37
Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci (1996) 1.36
Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry (1995) 1.34
GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex (1996) 1.31
Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry (1998) 1.26
Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression. J Neurochem (2001) 1.24
Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse (1998) 1.24
Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology (Berl) (1993) 1.23
High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther (1994) 1.21
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry (2002) 1.20
Genomics and array technology. Curr Opin Oncol (1999) 1.19
Gene expression profiling of aging using DNA microarrays. Mech Ageing Dev (2002) 1.19
Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann Neurol (1999) 1.17
Synaptic organization of the striatum. J Electron Microsc Tech (1988) 1.16
The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res (1990) 1.11
The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J Pharmacol Exp Ther (1995) 1.10
The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J Pharmacol Exp Ther (1996) 1.07
Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats. J Pharmacol Exp Ther (1999) 1.06
Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res (1995) 1.06
Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann Neurol (1999) 1.05
Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol (2001) 1.04
Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry (1997) 1.04
Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study. Brain Res (1980) 1.04
Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem (1993) 1.03
Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol Biochem Behav (1985) 1.01
Cocaine use increases [3H]WIN 35428 binding sites in human striatum. Brain Res (1993) 1.01
Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A (1991) 1.00
Cocaine-responsive gene expression changes in rat hippocampus. Neuroscience (2001) 0.98
Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Ther (1993) 0.95
Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. J Neurosci (1997) 0.94
Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine. Brain Res (1994) 0.94
NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport (1996) 0.92
mu-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J Neurosci (1997) 0.91
Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry (1997) 0.89
Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem (1994) 0.86
Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration. Brain Res Mol Brain Res (1997) 0.85
Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. Am J Psychiatry (1994) 0.85
[125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain. J Neurochem (1993) 0.84
Recent advances in the biology of addiction. Curr Psychiatry Rep (1999) 0.82
Kainic acid lesions of the nucleus accumbens selectively attenuate morphine self-administration. Pharmacol Biochem Behav (1988) 0.82
Inositol levels are decreased in postmortem brain of schizophrenic patients. Biol Psychiatry (1998) 0.82
Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia. Biol Psychiatry (1999) 0.81
Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia. J Neural Transm (Vienna) (1997) 0.77
In pursuit of the molecular neuropathology of schizophrenia. Arch Gen Psychiatry (1995) 0.76
Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem (2003) 1.42
Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling. Nat Protoc (2006) 1.40
Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine- and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex. Eur J Neurosci (2010) 1.30
Aerobic exercise attenuates reinstatement of cocaine-seeking behavior and associated neuroadaptations in the prefrontal cortex. Biol Psychiatry (2010) 1.24
Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Eur J Neurosci (2004) 1.22
Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats. J Neurochem (2004) 1.19
Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res (2004) 1.16
Proteomics for protein expression profiling in neuroscience. Neurochem Res (2004) 1.08
Discrete cell gene profiling of ventral tegmental dopamine neurons after acute and chronic cocaine self-administration. J Pharmacol Exp Ther (2003) 1.03
Self-administered heroin and cocaine combinations in the rat: additive reinforcing effects-supra-additive effects on nucleus accumbens extracellular dopamine. Neuropsychopharmacology (2006) 1.03
Methods for proteomics in neuroscience. Prog Brain Res (2006) 0.98
De novo protein sequence analysis of Macaca mulatta. BMC Genomics (2007) 0.93
Ethanol self-administration modulation of NMDA receptor subunit and related synaptic protein mRNA expression in prefrontal cortical fields in cynomolgus monkeys. Brain Res (2010) 0.91
Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology (2013) 0.87
Monkey alcohol tissue research resource: banking tissues for alcohol research. Alcohol Clin Exp Res (2014) 0.86
Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. Pharmacol Biochem Behav (2011) 0.85
Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. J Neurochem (2003) 0.85
Region specific regulation of NR1 in rhesus monkeys following chronic antipsychotic drug administration. Biol Psychiatry (2006) 0.83
Speedball induced changes in electrically stimulated dopamine overflow in rat nucleus accumbens. Neuropharmacology (2010) 0.79
Alternative splicing of AMPA subunits in prefrontal cortical fields of cynomolgus monkeys following chronic ethanol self-administration. Front Psychiatry (2012) 0.79
Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self-administration. J Neurochem (2012) 0.79
Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding. J Neuroimmune Pharmacol (2015) 0.79
Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor. Nat Commun (2013) 0.78
Quantitation in two-dimensional fluorescence difference gel electrophoresis: effect of protein fixation. Electrophoresis (2006) 0.78
Dopaminergic dysregulation in prefrontal cortex of rhesus monkeys following cocaine self-administration. Front Psychiatry (2013) 0.78
Changes in dopamine transporter binding in nucleus accumbens following chronic self-administration cocaine: heroin combinations. Synapse (2014) 0.77
Molecular mapping of striatal subdivisions in juvenile Macaca Mulata. Exp Neurol (2006) 0.75